Database

Startups

Main Industry
Health Care
Main Product/Service
Collagen Solution
3D Collagen Printing Gel (3D ColLive Gel)
Non-recombinant Porous Collagen Matrix (nPCM)
Regenerative Medicine Dermis (RegDerm)
Collagen and Related Derivative Product Technical Services
Founded Year
2022
Unified Business No.
90401152
Status
Active
Number of Employees
0
Total Paid-in Capital
40,108,600 (NT$)
Location of Company
Taiwan , Tainan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
FMG Biomed has developed nPCM, a patented non-reconstituted porous collagen matrix that prevents scaffold collapse. Its flagship RegDerm™ dermal prosthesis accelerates fibroblast infiltration 4× faster than global benchmarks — targeting wound care, tissue engineering, and ischemic wounds through U.S. distribution partnerships and CDMO collaborations.



More ↓

Similar Companies